Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
R&D Systems™ Recombinant Human BTN1A1/Butyrophilin His Avi Protein
Click to view available options
Quantity:
50 μg
Description
The biotin to protein ratio is greater than 0.7 as determined by the HABA assay. Measured by its ability to inhibit anti-CD3 antibody induced IL-2 secretion in human T lymphocytes. The ED50 for this effect is 0.5-3 μg/mL. Measured by its binding ability in a functional ELISA. When Rabbit Anti-Human BTN1A1/Butyrophilin Monoclonal Antibody (Catalog # MAB84671 ) is immobilized at 10 μg/mL (100 μL/well), the concentration of Biotinylated Recombinant Human BTN1A1/Butyrophilin His-tag Avi-tag (Catalog # AVI8467) that produces 50% of the optimal binding response is 0.01-0.1 μg/mL.
Specifications
Specifications
Accession Number | Q13410 |
For Use With (Application) | Bioactivity |
Formulation | Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. |
Gene ID (Entrez) | 696 |
Molecular Weight (g/mol) | M.W. (Observed): 30-43 kDa, under reducing conditions; M.W. (theoretical): 27 kDa |
Purification Method | >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining |
Quantity | 50 μg |
Source | Human embryonic kidney cell, HEK293-derived human BTN1A1/Butyrophilin protein Human BTN1A1/Butyrophilin (Ala27-Arg242) (N-terminus) Accession # Q13410 HHHHHH Avi-tag (C-terminus) |
Storage Requirements | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution. |
Endotoxin Concentration | <0.10 EU / 1 μg of the protein by the LAL method. |
Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction